IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Is Investigating the Following Companies; Shareholders are Encouraged to Contact the Firm – CGIX, BYFC, BMCH, AKCA

NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:

Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX in exchange for a number of shares of its common stock, with current equity holders of Cancer Genetics expected to own 22% of the common stock of the combined company. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/cancer-genetics-inc-cgix-stock-merger-stemonix/.

Broadway Financial Corporation (NASDAQ: BYFC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with CFBanc Corporation. Under the terms of the merger agreement, CFBanc common shareholders will receive 13.626 shares of Broadway Financial common stock for each share of CFBanc common stock they own. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/broadway-financial-corporation-byfc-stock-merger-cfbanc/.

BMC Stock Holdings, Inc. (NASDAQ: BMCH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Builders FirstSource, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builders FirstSource common stock for each share of BMC common stock. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/bmc-stock-holdings-inc-bmch-stock-merger-builders-firstsource/.

Akcea Therapeutics, Inc. (NASDAQ: AKCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ionis Pharmaceuticals, Inc. Under the terms of the agreement, Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, for $18.15 per share in cash. Visit our website to learn more about your legal rights and options: https://halpersadeh.com/actions/akcea-therapeutics-inc-akca-stock-merger-ionis/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP 



View source version on accesswire.com:
https://www.accesswire.com/607619/IMPORTANT-SHAREHOLDER-ALERT-Halper-Sadeh-LLP-Is-Investigating-the-Following-Companies-Shareholders-are-Encouraged-to-Contact-the-Firm-CGIX-BYFC-BMCH-AKCA

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X